✨ Your Portfolio is fetched and updated from zerodha.

Astec Lifesciences Ltd.

ASTEC

Market Cap
₹1,941 Cr.
P/E
0.00

Astec Lifesciences Ltd.

  • Astec Lifesciences
  • Meghmani Organics
  • India Pesticides
FAQs on Astec Lifesciences Ltd. Shareprice

Astec Lifesciences has given lower returns compared to its competitors.
Astec Lifesciences has grown at ~-14.54% over the last 3yrs while peers have grown at a median rate of -11.69%

Astec Lifesciences is not expensive.
Latest PE of Astec Lifesciences is 0.0, while 3 year average PE is 54.05.
Also latest EV/EBITDA of Astec Lifesciences is 0.0 while 3yr average is 29.15.

View FAQ's On Business
Growth Table
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Balance Sheet
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Cash Flow
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Quarterly Results
  • Astec Lifesciences Ltd.
  • Meghmani Organics
  • India Pesticides
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Astec Lifesciences Ltd. Financials

Balance sheet of Astec Lifesciences is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Astec Lifesciences is increasing.
Latest debt of Astec Lifesciences is ₹498 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹489 Crs.

No, profit is decreasing.
The profit of Astec Lifesciences is -₹103.56 Crs for TTM, -₹46.93 Crs for Mar 2024 and ₹25.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astec Lifesciences latest dividend payout ratio is 11.5% and 3yr average dividend payout ratio is 7.39%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech